Medifast, Inc. (MED)

NYSE: MED · Real-Time Price · USD

12.15

-0.11 (-0.90%)

At close: Oct 30, 2026, 4:00 PM EDT

12.17

+0.02 (0.16%)

After-hours: Oct 30, 2026, 7:30 PM EDT

Medifast Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	299.57	385.79	602.46	1,072	1,599	1,526
Revenue Growth	-30.28%	-35.97%	-43.80%	-32.94%	4.75%	63.24%
Gross Profit	207.33	275.19	444.62	775.85	1,140	1,128
Operating Income	-34.78	-14.21	15.38	126.4	184.81	216.24
Net Income	-40.85	-18.67	2.09	99.42	143.57	164.03
Earnings Per Share	-3.69	-1.70	0.19	9.10	12.73	13.89
EPS Growth	-	-	-97.91%	-28.52%	-8.35%	60.02%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	172.53	167.27	162.34	150.04	87.69	109.54
Total Debt	20.69	10.69	16.13	22.01	26.05	32.54
Net Cash (Debt)	151.85	156.58	146.22	128.03	61.64	77
Net Cash Growth	-5.83%	7.08%	14.21%	107.70%	-19.95%	-52.85%
Net Cash Per Share	13.71	14.26	13.34	11.72	5.47	6.52

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-0.03	6.86	24.48	147.66	194.57	94.55
Capital Expenditures	-3.84	-5.61	-7.45	-6.48	-16.68	-34.21
Free Cash Flow	-3.87	1.25	17.02	141.17	177.89	60.34
Free Cash Flow Growth	-	-92.66%	-87.94%	-20.64%	194.83%	-56.69%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	69.21%	71.33%	73.80%	72.37%	71.34%	73.89%
Operating Margin	-11.61%	-3.68%	2.55%	11.79%	11.56%	14.17%
Pretax Margin	-9.73%	-1.46%	0.63%	12.01%	11.51%	14.16%
Profit Margin	-13.64%	-4.84%	0.35%	9.27%	8.98%	10.75%
FCF Margin	-1.29%	0.32%	2.83%	13.17%	11.13%	3.95%

Dividends

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	4.950	6.560	5.680
Dividend Per Share Growth	-24.54%	15.49%	25.66%
Dividend Yield	7.37%	5.66%	2.71%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	89.76	7.29	8.73	14.78
Forward PE	-	53.77	38.00	13.05	9.03	13.75
P/FCF Ratio	-	87.88	11.03	5.13	7.05	40.17
PS Ratio	0.42	0.28	0.31	0.68	0.78	1.59